Risk of new-onset osteoporosis in single-center veteran population receiving direct oral anticoagulants versus warfarin.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Oral anticoagulants (OAC) have shown to affect bone mineral density and cause osteoporosis. Limited studies have investigated the relationship between its use and risk of osteoporosis. We aim to compare the risk of osteoporosis in patients on warfarin versus direct oral anticoagulants (DOACs).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Thromb Res

Title: Thrombosis research

Publisher: Elsevier BV

ISSN (Electronic): 1879-2472

ISSN (Print): 0049-3848

Publication date (Electronic): Apr 2021

Volume: 200

Affiliations

[1 ] Anticoagulation Program Manager, Clinical Pharmacy Specialist, Salem Veterans Affair Medical Center, Department of Pharmacy, Salem, Virginia. Electronic address: tanvipatil@gmail.com.

[2 ] Salem Veterans Affair Medical Center, Quality Management-Program Analyst.

Article

Publisher Item ID: S0049-3848(21)00038-4

DOI: 10.1016/j.thromres.2021.01.019

PubMed ID: 33540293

SO-VID: 81dcf8f8-c040-4f1b-979c-8eacc92369f5

History

Data availability:

Comments

Comment on this article

scite_

Cited by 2

See all cited by